Abstract
Epicardial adipose tissue (EAT) is a peculiar visceral fat depot with both protective and detrimental properties. The physiological role of EAT within the heart is complex and not completely understood. EAT functions can be distinguished in (1) nutritional, (2) metabolic, (3) thermogenic, (4) regulatory, and (5) mechanical. Under normal physiological EAT serves as a buffer, absorbing fatty acids and protecting the heart against high fatty acids levels and as pad protecting abnormal curvature of the coronary arteries. EAT is enriched in genes coding for cardioprotective adipokines such as adiponectin and adrenomedullin, both with potential anti-inflammatory and anti-atherogenic properties. EAT could also function as local energy source at times of high demand, channeling fatty acids to the myocardium and as brown fat to defend the myocardium against hypothermia. EAT expresses genes and secretes cytokines actively involved in the thermogenesis and regulation of lipid and glucose metabolism of the adjacent myocardium. EAT may adapt itself to different metabolic circumstances and function as brown-like or beige fat depot as needed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Marchington JM, Pond CM. Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. Int J Obes. 1990;14:1013–22.
Vural B, Atalar F, Ciftci C, Demirkan A, Susleyici-Duman B, Gunay D. Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome. Cardiovasc Pathol. 2008;17:392–8.
Pezeshkian M, Mahtabipour MR. Epicardial and subcutaneous adipose tissue fatty acids profiles in diabetic and non-diabetic patients candidate for coronary artery bypass graft. Bioimpacts. 2013;3:83–9.
Marchington JM, Mattacks CA, Pond CM. Adipose tissue in the mammalian heart and pericardium; structure, foetal development and biochemical properties. Comp Biochem Physiol. 1989;94B:225–32.
Iacobellis G, Bianco AC. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab. 2011;22:450–7.
Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005;2:536–43.
Judkin JS, Eringa E, Stehouwer CD. “Vasocrine signalling” from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet. 2005;365:1817–20.
Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108:2460–6.
Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004;24:29–33. Review.
Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism. 2003;52:1274–8.
Staiger H, Tschritter O, Machann J, Thamer C, Fritsche A, Maerker E, et al. Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res. 2003;11:368–72.
Iacobellis G, Barbaro G. The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm Metab Res. 2008;40:442–5.
Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G, et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with CAD. Cytokine. 2005;29:251–5.
Iacobellis G, di Gioia CR, Cotesta D, Petramala L, Travaglini C, De Santis V, et al. Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels. Horm Metab Res. 2009;41:227–31.
Iacobellis G, Cotesta D, Petramala L, De Santis V, Vitale D, Tritapepe L, Letizia C. Intracoronary adiponectin levels rapidly and significantly increase after coronary revascularization. Int J Cardiol. 2010;144:160–3.
Ishimitsu T, Ono H, Minami J, Matsuoka H. Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders. Pharmacol Ther. 2006;111:909–27.
Bunton DC, Petrie MC, Hillier C, Johnston F, McMurray JJV. The clinical relevance of adrenomedullin: a promising profile? Pharmacol Ther. 2004;103:179–201.
Yasu T, Nishikimi T, Kobayashi N, Ikeda N, Ueba H, Nakamura T, et al. Up-regulated synthesis of mature-type adrenomedullin in coronary circulation immediately after reperfusion in patients with anterior acute myocardial infarction. Regul Pept. 2005;129(1–3):161–6.
Kobayashi K, Kitamura K, Hirayama N, Date H, Kashiwagi T, Ikushima I, et al. Increased plasma adrenomedullin in acute myocardial infarction. Am Heart J. 1996;131:676–80.
Hamid SA, Baxter GF. A critical cytoprotective role of endogenous adrenomedullin in acute myocardial infarction. J Mol Cell Cardiol. 2006;41:360–3.
Hojo Y, Uichi I, Katsuki T, Shimada K. Decreased adrenomedullin production in the coronary circulation of patients with coronary artery disease. Heart. 2000;84(1):88.
Silaghi A, Achard V, Paulmyer-Lacroix O, Scridon T, Tassistro V, Duncea I, et al. Expression of adrenomedullin in human epicardial adipose tissue: role of coronary status. Am J Physiol Endocrinol Metab. 2007;293:E1443–50.
Fosshaug LE, Dahl CP, Risnes I, Bohov P, Berge RK, Nymo S, et al. Altered levels of fatty acids and inflammatory and metabolic mediators in epicardial adipose tissue in patients with systolic heart failure. J Card Fail. 2015;21:916–23.
Iacobellis G, di Goia CR, Di Vito M, Petramala L, Cotesta D, De Santis V, et al. Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease. Horm Metab Res. 2009;41:855–60.
Fernández-Trasancos Á, Agra RM, García-Acuña JM, Fernández ÁL, González-Juanatey JR, Eiras S. Omentin treatment of epicardial fat improves its anti-inflammatory activity and paracrine benefit on smooth muscle cells. Obesity (Silver Spring). 2017;25:1042–9.
Du Y, Ji Q, Cai L, Huang F, Lai Y, Liu Y, et al. Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis. Cardiovasc Diabetol. 2016;15:90.
Harada K, Shibata R, Ouchi N, Tokuda Y, Funakubo H, Suzuki M, et al. Increased expression of the adipocytokine omentin in the epicardial adipose tissue of coronary artery disease patients. Atherosclerosis. 2016;251:299–304.
Matloch Z, Kratochvílová H, Cinkajzlová A, Lipš M, Kopecký P, Pořízka M, et al. Changes in omentin levels and its mRNA expression in epicardial adipose tissue in patients undergoing elective cardiac surgery: the influence of type 2 diabetes and coronary heart disease. Physiol Res. 2018;67:881–90.
Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab. 2007;293:E444–52.
Heaton JM. The distribution of brown adipose tissue in the human. J Anat. 1972;112:35–9.
Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009;360:1509–17.
Iacobellis G, Di Gioia C, Petramala L, Chiappetta C, Serra V, Zinnamosca L, et al. Brown fat expresses adiponectin in humans. Int J Endocrinol. 2013;2013:126751.
Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J. 2007;153:907–17.
Sacks HS, Fain JN, Holman B, Cheema P, Chary A, Parks F. Uncoupling protein-1 and related mRNAs in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. J Clin Endocrinol Metab. 2009;94:3611–5.
Sacks HS, Fain JN, Bahouth SW, Ojha S, Frontini A, Budge H, et al. Human epicardial fat exhibits beige features. J Clin Endocrinol Metab. 2013;98:E1448–55.
Ojha S, Fainberg HP, Wilson V, Pelella G, Castellanos M, May ST, et al. Gene pathway development in human epicardial adipose tissue during early life. JCI Insight. 2016;1:e87460.
Fainberg HP, Birtwistle M, Alagal R, Alhaddad A, Pope M, Davies G, et al. Transcriptional analysis of adipose tissue during development reveals depot-specific responsiveness to maternal dietary supplementation. Sci Rep. 2018;8:9628.
McAninch EA, Fonseca TL, Poggioli R, Panos AL, Salerno TA, Deng Y, et al. Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease. Obesity. 2015;23:1267–78.
Singh SP, McClung JA, Thompson E, Glick Y, Greenberg M, Acosta-Baez G, et al. Cardioprotective effect of heme oxygenase-1-PGC-1α signaling in epicardial fat attenuates cardiovascular risk in humans as in obese mice. Obesity (Silver Spring). 2019;27:1634–43.
Svensson PA, Jernas M, Sjoholm K, Hoffmann JM, Nilsson BE, Hansson M, et al. Gene expression in human brown adipose tissue. Int J Mol Med. 2011;27:227–32.
Chechi K, Vijay J, Voisine P, Mathieu P, Bossé Y, Tchernof A, et al. UCP1 expression-associated gene signatures of human epicardial adipose tissue. JCI Insight. 2019;4:e123618.
Regan SE, Broad M, Byford AM, Lankford AR, Cerniway RJ, Mayo MW, et al. A1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activity. Am J Physiol Heart Circ Physiol. 2003;284:H859–66.
Prati F, Arbustini E, Labellarte A, Sommariva L, Pawlowski T, Manzoli A, et al. Eccentric atherosclerotic plaques with positive remodelling have a pericardial distribution: a permissive role of epicardial fat? A three-dimensional intravascular ultrasound study of left anterior descending artery lesions. Eur Heart J. 2003;24:329–36.
Fei J, Cook C, Blough E, Santanam N. Age and sex mediated changes in epicardial fat adipokines. Atherosclerosis. 2010;212:488–94.
Kocher C, Christiansen M, Martin S, Adams C, Wehner P, Gress T, Santanam N. Sexual dimorphism in obesity-related genes in the epicardial fat during aging. J Physiol Biochem. 2017;73:215–24.
Richards EM, McElhaney E, Zeringue K, Joseph S, Keller-Wood M. Transcriptomic evidence that cortisol alters perinatal epicardial adipose tissue maturation. Am J Physiol Endocrinol Metab. 2019;317:E573–85.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Iacobellis, G. (2020). Physiology and Cardioprotection of the Epicardial Adipose Tissue. In: Iacobellis, G. (eds) Epicardial Adipose Tissue. Contemporary Cardiology. Humana, Cham. https://doi.org/10.1007/978-3-030-40570-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-40570-0_2
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-030-40569-4
Online ISBN: 978-3-030-40570-0
eBook Packages: MedicineMedicine (R0)